Clinical trial
A Phase 3 Multicenter, Open-Label, 52-Week Study To Evaluate the Long-Term Safety and Tolerability of NKTR-181 in Subjects With Moderate to Severe Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 is registered in ClinicalTrials.gov with Nektar Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multicenter, Open-Label, 52-Week Study To Evaluate the Long-Term Safety and Tolerability of NKTR-181 in Subjects With Moderate to Severe Chronic Low Back Pain or Chronic Non-Cancer Pain
- Lead sponsor
- Nektar Therapeutics
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 14, 2015
- Completion date
- January 31, 2018
- Enrollment
- 638 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.